Peter Nash Selected Research

Peter Nash Research Topics

Disease

51	Psoriatic Arthritis 10/2022 - 06/2004
38	Rheumatoid Arthritis 04/2022 - 06/2004
20	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2022 - 06/2004
13	Infections 04/2022 - 08/2014
7	Ankylosing Spondylitis 10/2021 - 07/2006
7	Necrosis 01/2021 - 11/2013
6	Neoplasms (Cancer) 04/2022 - 08/2014
6	Systemic Scleroderma (Systemic Sclerosis) 09/2016 - 09/2009
5	Herpes Zoster 04/2022 - 01/2016
5	Fatigue 01/2022 - 05/2007
5	Pain (Aches) 12/2021 - 12/2016
5	Arthritis (Polyarthritis) 09/2020 - 05/2007
4	Pulmonary Arterial Hypertension 09/2016 - 11/2011
3	Chronic Disease (Chronic Diseases) 01/2022 - 01/2019
3	Ulcerative Colitis 01/2021 - 01/2019
2	Nail Diseases (Nail Disease) 05/2022 - 05/2007
2	Diarrhea 04/2022 - 06/2004
2	Headache (Headaches) 04/2022 - 02/2022
2	Crohn Disease (Crohn's Disease) 11/2020 - 01/2019
2	Injection Site Reaction 01/2019 - 08/2014
2	Dyspnea (Shortness of Breath) 10/2009 - 06/2008
1	Nasopharyngitis 04/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022
1	Tuberculosis (Tuberculoses) 04/2022
1	Dyspepsia (Indigestion) 04/2022
1	Anemia 04/2022
1	Oral Candidiasis (Thrush) 04/2022
1	Opportunistic Infections (Opportunistic Infection) 04/2022
1	Nausea 04/2022
1	Axial Spondyloarthritis 10/2021
1	Non-Radiographic Axial Spondyloarthritis 10/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2020
1	Atopic Dermatitis (Atopic Eczema) 11/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Hypersensitivity (Allergy) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Candidiasis (Moniliasis) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Body Weight (Weight, Body) 06/2018
1	Rheumatic Diseases (Rheumatism) 06/2018
1	Stroke (Strokes) 10/2015
1	Myocardial Infarction 10/2015
1	Pulmonary Hypertension 01/2013
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2012

Drug/Important Bio-Agent (IBA)

25	Methotrexate (Mexate)FDA LinkGeneric 02/2022 - 09/2006
16	Antirheumatic Agents (DMARD)IBA 10/2022 - 09/2006
16	Adalimumab (Humira)FDA Link 04/2022 - 12/2016
16	Janus Kinase InhibitorsIBA 04/2022 - 06/2017
16	Biological ProductsIBA 04/2022 - 08/2009
15	tofacitinibIBA 04/2022 - 03/2013
14	secukinumabIBA 05/2022 - 10/2015
12	ixekizumabIBA 10/2022 - 10/2017
9	ametantrone (HAQ)IBA 02/2022 - 11/2011
6	upadacitinibIBA 08/2022 - 01/2021
6	Etanercept (Enbrel)FDA Link 10/2021 - 03/2013
6	golimumab FDA Link 11/2018 - 04/2008
5	Tumor Necrosis Factor InhibitorsIBA 03/2021 - 06/2017
5	Abatacept (Orencia)FDA Link 01/2018 - 05/2013
4	GlucocorticoidsIBA 01/2018 - 05/2003
3	GLPG0634IBA 02/2022 - 01/2021
3	Janus KinasesIBA 01/2022 - 06/2017
3	apremilastIBA 12/2021 - 01/2018
3	Infliximab (Remicade)FDA Link 01/2019 - 06/2017
3	Monoclonal AntibodiesIBA 10/2017 - 08/2009
3	Leflunomide (Arava)FDA LinkGeneric 06/2017 - 06/2004
3	Biomarkers (Surrogate Marker)IBA 09/2016 - 10/2009
3	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2016 - 06/2012
2	Creatine Kinase (Creatine Phosphokinase)IBA 04/2022 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 10/2017 - 10/2015
2	pro-brain natriuretic peptide (1-76)IBA 01/2013 - 06/2012
1	vinyltriethoxysilane (VTES)IBA 04/2022
1	Hemoglobins (Hemoglobin)IBA 02/2022
1	Prostaglandins AIBA 02/2022
1	N-phthaloylglutamic acidIBA 12/2021
1	C-Reactive ProteinIBA 10/2021
1	N-(4-iodophenethyl)maleimide (IPEM)IBA 09/2021
1	5-(tetradecyloxy)-2-furancarboxylic acid (TOFA)IBA 11/2020
1	guselkumabIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	InterleukinsIBA 01/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2020
1	Ustekinumab (CNTO 1275)FDA Link 11/2018
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2017
1	sarilumabIBA 06/2017
1	baricitinibIBA 06/2017
1	clazakizumabIBA 06/2017
1	tocilizumab (atlizumab)FDA Link 06/2017
1	sirukumabIBA 06/2017
1	Certolizumab Pegol FDA Link 06/2017
1	Biosimilar PharmaceuticalsIBA 06/2017
1	Rituximab (Mabthera)FDA Link 06/2017
1	Excipients (Suspending Agents)IBA 12/2016
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 09/2016
1	RNA Polymerase IIIIBA 01/2011

Therapy/Procedure

14	Therapeutics 04/2022 - 07/2006
2	Activities of Daily Living (ADL) 10/2009 - 06/2008
1	Self Administration (Administration, Self) 01/2018
1	Aftercare (After-Treatment) 03/2013
1	Cardiac Catheters 06/2012